The biggest and most comprehensive analysis of glucagon-like peptide-1 (GLP-1) receptor agonists on kidney and cardiovascular outcomes shows they have significant benefits in people with and without diabetes.
source https://www.sciencedaily.com/releases/2024/11/241125195050.htm
Pharmaceuticals face 100% tariffs in US - unless firms strike a deal
-
The order does not affect generic medicines, the most commonly used in the
US.
source
https://www.bbc.com/news/articles/cx29kke01gpo?at_medium=RSS&at_camp...
23 hours ago
No comments:
Post a Comment